COFCO TECH(SZ:000930)2025-09-16 12:30Group 1: Company Overview and Market Position - COFCO Biotech is the only company approved to produce D-Alulose using specific enzymes in China, indicating a unique market position [1][2] - The company is actively expanding its D-Alulose market presence through self-built capacity and third-party collaborations [1][4] Group 2: Financial Performance and Stock Issuance - The non-public offering price is set at 9.38 CNY per share, while the current market price is 6.14 CNY, reflecting a significant discount [2][7] - The company aims to enhance shareholder value through strategic collaborations that exceed the capital value, compensating for the dilution of existing shareholders' equity [2][7] Group 3: Project Development and Future Plans - Current projects include a new starch sugar production facility with an annual capacity of 550,000 tons and a 30,000-ton lactide project, with ongoing expansions in Chengdu [2][7] - The D-Alulose project is expected to enter the food application market, with ongoing updates provided through regular reports and interactive platforms [1][4] Group 4: Regulatory and Market Environment - The company's strategy aligns with national policies promoting a unified market and reducing competition through technological upgrades rather than price competition [5][6] - The company has established a market value management system to enhance investment value and protect investor rights amid a significant market cap reduction of 5.9 billion CNY over seven years [7]